Conclusively, based on the results from these well-controlled in vitro and in vivo studies, it was speculated that the Keap1/Nrf2 signaling pathway is closely involved in the pathogenesis and progression of T1DM. This evidence concerns the gene NFE2L2 and type 1 diabetes mellitus.